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See related research by Wang et al. http://ccforum.com/content/18/4/R161In their study Wang and colleagues [1] found that
mobilization during continuous renal replacement therapy
(CRRT) is safe, and did not lead to filter circuit clotting.
However, I feel that this work raises two remarks.
First, by delivering CRRT via continuous venovenous
hemodiafiltration (CVVHDF) with a dialysate rate of
20 ml/kg/hour, a replacement fluid rate of 15 ml/kg/
hour and a low effluent fluid removal rate, the filtration
fraction, a major determinant of clotting, may have beenCorrespondence: frederic.jacobs@abc.aphp.fr
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unless otherwise stated.lower than the one resulting from continuous venove-
nous hemofiltration (CVVHF), which is as much used as
the CRRT mode [2]. Furthermore, details concerning the
blood flow (which impacts filtration fraction) are lacking.
Thus, generalization of these results should probably be
tempered.
Finally, regarding the exclusion criteria, the use of
intermittent hemodialysis may be the best way to ensure
daily patient mobilization, at a much lower cost [3].rWe read the letter by Jacobs with interest. We agree that
a combined dose of 35 ml/kg/hour (incorporating both
convective and diffusive clearance) in CVVHDF mode
would reduce filtration fraction compared with a pure
convective mode such as CVVHF. However, there is no
conclusive evidence that filter life is related to filtration
fraction, while there is some evidence to the contrary
[4]. Our original manuscript agreed that the generaliz-
ability of the results should be tempered and stated
that we felt large multi-center studies were warranted to
confirm the findings [1]. We agree that blood flow rates
in the circuit should be collected in such studies, as this
may be an independent confounding factor for circuit
life and filtration fraction. However, we conducted an
additional post hoc sensitivity analysis adjusting for blood
flow and the effect of the MOVE (movement on vascular
catheter evaluation) intervention on filter life was still sig-
nificant in our cohort (regression co-efficient (robust 95%
CI), P value = 14.3 hours (5.3, 23.3), P = 0.003).Moreover, mobilization restrictions placed on patients
undergoing CVVHDF via femoral vascath frequently
preclude the delivery of evidence-based practice [5, 6],
where early mobilization reduces ventilation duration
and ICU and hospital length of stay [7]. Whilst intermit-
tent hemodialysis is an alternative method of CRRT
delivery, CVVHDF is the therapy of choice in over 50%
of Australian ICUs (unpublished data). The aim of our
study was to test whether patients subjected to continuous
therapies via femoral access could be safely mobilized. We
reiterate our conclusions, which were that mobilization of
patients undergoing CRRT via femoral vascular access was
safe and feasible [1].Abbreviations
CRRT: Continuous renal replacement therapy; CVVHDF: Continuous venovenous
haemodiafiltration; CVVHF: Continuous venovenous haemofiltration.Competing interests
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